Santos David A 4

What Happened David A. Santos, EVP and Chief Commercial Officer of Rigel Pharmaceuticals (RIGL), had 874 shares disposed of on 2026-06-01 to satisfy a tax withholding obligation. The shares were valued at $29.86 each, totaling $26,098. This was a tax-withholding disposition (transaction code F), not an open-market sale.

Key Details

• Transaction date: 2026-06-01
• Price per share: $29.86; Shares surrendered: 874; Total value: $26,098
• Transaction code: F (payment of exercise price or tax liability / tax withholding)
• Filing date: 2026-06-03 (appears to be filed within the normal two-business-day window)
• Shares owned after the transaction: not specified in the provided filing excerpt
• Note: This is a withholding to cover taxes tied to equity (e.g., option exercise or RSU vesting), not an outright sale into the market

Context Code F transactions typically reflect the company withholding some shares to satisfy tax obligations from a vesting or option exercise (a form of cashless settlement). These are routine administrative transactions and do not necessarily indicate the insider is reducing their net economic exposure via market sales.